Allspring Global Investments
LYEL icon

Allspring Global Investments’s Lyell Immunopharma LYEL Stock Holding History

Allspring Global Investments’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Buy
+16,145
New +$292K ﹤0.01% 1636
2023
Q4 		– Sell
-620
Closed -$18.2K – 2518
2023
Q3 		$18.2K Sell
620
-10
-2% -$475 ﹤0.01% 2527
2023
Q2 		$40K Buy
630
+226
+56% +$12.5K ﹤0.01% 2338
2023
Q1 		$19.1K Buy
404
+325
+411% +$17.4K ﹤0.01% 2508
2022
Q4 		$5.47K Sell
79
-699
-90% -$69.4K ﹤0.01% 2776
2022
Q3 		$114K Buy
+778
New +$105K ﹤0.01% 2027

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Allspring Global Investments's LYEL Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Lyell Immunopharma (LYEL) in Q2 2026: 16,145 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #1636 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in LYEL as recently as Q3 2023.

Allspring Global Investments first reported a position in LYEL in Q3 2022 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Allspring Global Investments held 16,145 shares of Lyell Immunopharma worth $227K as of Q2 2026.
  • Lyell Immunopharma was a new Allspring Global Investments position in Q2 2026.
  • Lyell Immunopharma made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1636 holding.
  • Allspring Global Investments first reported a position in Lyell Immunopharma in Q3 2022 and has held it in 6 quarters since.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.